Engineered T Cells Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Engineered T Cells Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tumor Infiltrating Lymphocytes
1.2.3 T Cell Receptor {TCR}
1.2.4 Chimeric Antigen Receptor(CAR)
1.3 Market by Application
1.3.1 Global Engineered T Cells Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Engineered T Cells Market Perspective (2017-2028)
2.2 Engineered T Cells Growth Trends by Region
2.2.1 Engineered T Cells Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Engineered T Cells Historic Market Size by Region (2017-2022)
2.2.3 Engineered T Cells Forecasted Market Size by Region (2023-2028)
2.3 Engineered T Cells Market Dynamics
2.3.1 Engineered T Cells Industry Trends
2.3.2 Engineered T Cells Market Drivers
2.3.3 Engineered T Cells Market Challenges
2.3.4 Engineered T Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Engineered T Cells Players by Revenue
3.1.1 Global Top Engineered T Cells Players by Revenue (2017-2022)
3.1.2 Global Engineered T Cells Revenue Market Share by Players (2017-2022)
3.2 Global Engineered T Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Engineered T Cells Revenue
3.4 Global Engineered T Cells Market Concentration Ratio
3.4.1 Global Engineered T Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Engineered T Cells Revenue in 2021
3.5 Engineered T Cells Key Players Head office and Area Served
3.6 Key Players Engineered T Cells Product Solution and Service
3.7 Date of Enter into Engineered T Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Engineered T Cells Breakdown Data by Type
4.1 Global Engineered T Cells Historic Market Size by Type (2017-2022)
4.2 Global Engineered T Cells Forecasted Market Size by Type (2023-2028)
5 Engineered T Cells Breakdown Data by Application
5.1 Global Engineered T Cells Historic Market Size by Application (2017-2022)
5.2 Global Engineered T Cells Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Engineered T Cells Market Size (2017-2028)
6.2 North America Engineered T Cells Market Size by Type
6.2.1 North America Engineered T Cells Market Size by Type (2017-2022)
6.2.2 North America Engineered T Cells Market Size by Type (2023-2028)
6.2.3 North America Engineered T Cells Market Share by Type (2017-2028)
6.3 North America Engineered T Cells Market Size by Application
6.3.1 North America Engineered T Cells Market Size by Application (2017-2022)
6.3.2 North America Engineered T Cells Market Size by Application (2023-2028)
6.3.3 North America Engineered T Cells Market Share by Application (2017-2028)
6.4 North America Engineered T Cells Market Size by Country
6.4.1 North America Engineered T Cells Market Size by Country (2017-2022)
6.4.2 North America Engineered T Cells Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Engineered T Cells Market Size (2017-2028)
7.2 Europe Engineered T Cells Market Size by Type
7.2.1 Europe Engineered T Cells Market Size by Type (2017-2022)
7.2.2 Europe Engineered T Cells Market Size by Type (2023-2028)
7.2.3 Europe Engineered T Cells Market Share by Type (2017-2028)
7.3 Europe Engineered T Cells Market Size by Application
7.3.1 Europe Engineered T Cells Market Size by Application (2017-2022)
7.3.2 Europe Engineered T Cells Market Size by Application (2023-2028)
7.3.3 Europe Engineered T Cells Market Share by Application (2017-2028)
7.4 Europe Engineered T Cells Market Size by Country
7.4.1 Europe Engineered T Cells Market Size by Country (2017-2022)
7.4.2 Europe Engineered T Cells Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Engineered T Cells Market Size (2017-2028)
8.2 Asia-Pacific Engineered T Cells Market Size by Type
8.2.1 Asia-Pacific Engineered T Cells Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Engineered T Cells Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Engineered T Cells Market Share by Type (2017-2028)
8.3 Asia-Pacific Engineered T Cells Market Size by Application
8.3.1 Asia-Pacific Engineered T Cells Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Engineered T Cells Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Engineered T Cells Market Share by Application (2017-2028)
8.4 Asia-Pacific Engineered T Cells Market Size by Region
8.4.1 Asia-Pacific Engineered T Cells Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Engineered T Cells Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Engineered T Cells Market Size (2017-2028)
9.2 Latin America Engineered T Cells Market Size by Type
9.2.1 Latin America Engineered T Cells Market Size by Type (2017-2022)
9.2.2 Latin America Engineered T Cells Market Size by Type (2023-2028)
9.2.3 Latin America Engineered T Cells Market Share by Type (2017-2028)
9.3 Latin America Engineered T Cells Market Size by Application
9.3.1 Latin America Engineered T Cells Market Size by Application (2017-2022)
9.3.2 Latin America Engineered T Cells Market Size by Application (2023-2028)
9.3.3 Latin America Engineered T Cells Market Share by Application (2017-2028)
9.4 Latin America Engineered T Cells Market Size by Country
9.4.1 Latin America Engineered T Cells Market Size by Country (2017-2022)
9.4.2 Latin America Engineered T Cells Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Engineered T Cells Market Size (2017-2028)
10.2 Middle East & Africa Engineered T Cells Market Size by Type
10.2.1 Middle East & Africa Engineered T Cells Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Engineered T Cells Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Engineered T Cells Market Share by Type (2017-2028)
10.3 Middle East & Africa Engineered T Cells Market Size by Application
10.3.1 Middle East & Africa Engineered T Cells Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Engineered T Cells Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Engineered T Cells Market Share by Application (2017-2028)
10.4 Middle East & Africa Engineered T Cells Market Size by Country
10.4.1 Middle East & Africa Engineered T Cells Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Engineered T Cells Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Autolus Limited
11.1.1 Autolus Limited Company Details
11.1.2 Autolus Limited Business Overview
11.1.3 Autolus Limited Engineered T Cells Introduction
11.1.4 Autolus Limited Revenue in Engineered T Cells Business (2017-2022)
11.1.5 Autolus Limited Recent Developments
11.2 Bellicum Pharmaceuticals
11.2.1 Bellicum Pharmaceuticals Company Details
11.2.2 Bellicum Pharmaceuticals Business Overview
11.2.3 Bellicum Pharmaceuticals Engineered T Cells Introduction
11.2.4 Bellicum Pharmaceuticals Revenue in Engineered T Cells Business (2017-2022)
11.2.5 Bellicum Pharmaceuticals Recent Developments
11.3 Cells Medica
11.3.1 Cells Medica Company Details
11.3.2 Cells Medica Business Overview
11.3.3 Cells Medica Engineered T Cells Introduction
11.3.4 Cells Medica Revenue in Engineered T Cells Business (2017-2022)
11.3.5 Cells Medica Recent Developments
11.4 Elli Lilly and Company
11.4.1 Elli Lilly and Company Company Details
11.4.2 Elli Lilly and Company Business Overview
11.4.3 Elli Lilly and Company Engineered T Cells Introduction
11.4.4 Elli Lilly and Company Revenue in Engineered T Cells Business (2017-2022)
11.4.5 Elli Lilly and Company Recent Developments
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Details
11.5.2 Gilead Sciences Business Overview
11.5.3 Gilead Sciences Engineered T Cells Introduction
11.5.4 Gilead Sciences Revenue in Engineered T Cells Business (2017-2022)
11.5.5 Gilead Sciences Recent Developments
11.6 Juno Therapeutics
11.6.1 Juno Therapeutics Company Details
11.6.2 Juno Therapeutics Business Overview
11.6.3 Juno Therapeutics Engineered T Cells Introduction
11.6.4 Juno Therapeutics Revenue in Engineered T Cells Business (2017-2022)
11.6.5 Juno Therapeutics Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Engineered T Cells Introduction
11.7.4 Novartis Revenue in Engineered T Cells Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 Oxford Biomedica
11.8.1 Oxford Biomedica Company Details
11.8.2 Oxford Biomedica Business Overview
11.8.3 Oxford Biomedica Engineered T Cells Introduction
11.8.4 Oxford Biomedica Revenue in Engineered T Cells Business (2017-2022)
11.8.5 Oxford Biomedica Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Engineered T Cells Introduction
11.9.4 Pfizer Revenue in Engineered T Cells Business (2017-2022)
11.9.5 Pfizer Recent Developments
11.10 Precision Bioscience
11.10.1 Precision Bioscience Company Details
11.10.2 Precision Bioscience Business Overview
11.10.3 Precision Bioscience Engineered T Cells Introduction
11.10.4 Precision Bioscience Revenue in Engineered T Cells Business (2017-2022)
11.10.5 Precision Bioscience Recent Developments
11.11 Redmile Group
11.11.1 Redmile Group Company Details
11.11.2 Redmile Group Business Overview
11.11.3 Redmile Group Engineered T Cells Introduction
11.11.4 Redmile Group Revenue in Engineered T Cells Business (2017-2022)
11.11.5 Redmile Group Recent Developments
11.12 Seeking Alpha
11.12.1 Seeking Alpha Company Details
11.12.2 Seeking Alpha Business Overview
11.12.3 Seeking Alpha Engineered T Cells Introduction
11.12.4 Seeking Alpha Revenue in Engineered T Cells Business (2017-2022)
11.12.5 Seeking Alpha Recent Developments
11.13 Unum Therapeutics
11.13.1 Unum Therapeutics Company Details
11.13.2 Unum Therapeutics Business Overview
11.13.3 Unum Therapeutics Engineered T Cells Introduction
11.13.4 Unum Therapeutics Revenue in Engineered T Cells Business (2017-2022)
11.13.5 Unum Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Engineered T Cells Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Tumor Infiltrating Lymphocytes
Table 3. Key Players of T Cell Receptor {TCR}
Table 4. Key Players of Chimeric Antigen Receptor(CAR)
Table 5. Global Engineered T Cells Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Engineered T Cells Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Engineered T Cells Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Engineered T Cells Market Share by Region (2017-2022)
Table 9. Global Engineered T Cells Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Engineered T Cells Market Share by Region (2023-2028)
Table 11. Engineered T Cells Market Trends
Table 12. Engineered T Cells Market Drivers
Table 13. Engineered T Cells Market Challenges
Table 14. Engineered T Cells Market Restraints
Table 15. Global Engineered T Cells Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Engineered T Cells Revenue Share by Players (2017-2022)
Table 17. Global Top Engineered T Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered T Cells as of 2021)
Table 18. Ranking of Global Top Engineered T Cells Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Engineered T Cells Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Engineered T Cells Product Solution and Service
Table 22. Date of Enter into Engineered T Cells Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Engineered T Cells Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Engineered T Cells Revenue Market Share by Type (2017-2022)
Table 26. Global Engineered T Cells Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Engineered T Cells Revenue Market Share by Type (2023-2028)
Table 28. Global Engineered T Cells Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Engineered T Cells Revenue Share by Application (2017-2022)
Table 30. Global Engineered T Cells Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Engineered T Cells Revenue Share by Application (2023-2028)
Table 32. North America Engineered T Cells Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Engineered T Cells Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Engineered T Cells Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Engineered T Cells Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Engineered T Cells Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Engineered T Cells Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Engineered T Cells Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Engineered T Cells Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Engineered T Cells Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Engineered T Cells Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Engineered T Cells Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Engineered T Cells Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Engineered T Cells Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Engineered T Cells Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Engineered T Cells Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Engineered T Cells Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Engineered T Cells Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Engineered T Cells Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Engineered T Cells Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Engineered T Cells Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Engineered T Cells Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Engineered T Cells Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Engineered T Cells Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Engineered T Cells Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Engineered T Cells Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Engineered T Cells Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Engineered T Cells Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Engineered T Cells Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Engineered T Cells Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Engineered T Cells Market Size by Country (2023-2028) & (US$ Million)
Table 62. Autolus Limited Company Details
Table 63. Autolus Limited Business Overview
Table 64. Autolus Limited Engineered T Cells Product
Table 65. Autolus Limited Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 66. Autolus Limited Recent Developments
Table 67. Bellicum Pharmaceuticals Company Details
Table 68. Bellicum Pharmaceuticals Business Overview
Table 69. Bellicum Pharmaceuticals Engineered T Cells Product
Table 70. Bellicum Pharmaceuticals Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 71. Bellicum Pharmaceuticals Recent Developments
Table 72. Cells Medica Company Details
Table 73. Cells Medica Business Overview
Table 74. Cells Medica Engineered T Cells Product
Table 75. Cells Medica Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 76. Cells Medica Recent Developments
Table 77. Elli Lilly and Company Company Details
Table 78. Elli Lilly and Company Business Overview
Table 79. Elli Lilly and Company Engineered T Cells Product
Table 80. Elli Lilly and Company Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 81. Elli Lilly and Company Recent Developments
Table 82. Gilead Sciences Company Details
Table 83. Gilead Sciences Business Overview
Table 84. Gilead Sciences Engineered T Cells Product
Table 85. Gilead Sciences Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 86. Gilead Sciences Recent Developments
Table 87. Juno Therapeutics Company Details
Table 88. Juno Therapeutics Business Overview
Table 89. Juno Therapeutics Engineered T Cells Product
Table 90. Juno Therapeutics Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 91. Juno Therapeutics Recent Developments
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Engineered T Cells Product
Table 95. Novartis Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 96. Novartis Recent Developments
Table 97. Oxford Biomedica Company Details
Table 98. Oxford Biomedica Business Overview
Table 99. Oxford Biomedica Engineered T Cells Product
Table 100. Oxford Biomedica Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 101. Oxford Biomedica Recent Developments
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Engineered T Cells Product
Table 105. Pfizer Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 106. Pfizer Recent Developments
Table 107. Precision Bioscience Company Details
Table 108. Precision Bioscience Business Overview
Table 109. Precision Bioscience Engineered T Cells Product
Table 110. Precision Bioscience Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 111. Precision Bioscience Recent Developments
Table 112. Redmile Group Company Details
Table 113. Redmile Group Business Overview
Table 114. Redmile Group Engineered T Cells Product
Table 115. Redmile Group Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 116. Redmile Group Recent Developments
Table 117. Seeking Alpha Company Details
Table 118. Seeking Alpha Business Overview
Table 119. Seeking Alpha Engineered T Cells Product
Table 120. Seeking Alpha Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 121. Seeking Alpha Recent Developments
Table 122. Unum Therapeutics Company Details
Table 123. Unum Therapeutics Business Overview
Table 124. Unum Therapeutics Engineered T Cells Product
Table 125. Unum Therapeutics Revenue in Engineered T Cells Business (2017-2022) & (US$ Million)
Table 126. Unum Therapeutics Recent Developments
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Engineered T Cells Market Share by Type: 2021 VS 2028
Figure 2. Tumor Infiltrating Lymphocytes Features
Figure 3. T Cell Receptor {TCR} Features
Figure 4. Chimeric Antigen Receptor(CAR) Features
Figure 5. Global Engineered T Cells Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Cancer Research Centers Case Studies
Figure 8. Clinics Case Studies
Figure 9. Engineered T Cells Report Years Considered
Figure 10. Global Engineered T Cells Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Engineered T Cells Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Engineered T Cells Market Share by Region: 2021 VS 2028
Figure 13. Global Engineered T Cells Market Share by Players in 2021
Figure 14. Global Top Engineered T Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered T Cells as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Engineered T Cells Revenue in 2021
Figure 16. North America Engineered T Cells Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Engineered T Cells Market Size Market Share by Type (2017-2028)
Figure 18. North America Engineered T Cells Market Size Market Share by Application (2017-2028)
Figure 19. North America Engineered T Cells Market Size Share by Country (2017-2028)
Figure 20. United States Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Engineered T Cells Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Engineered T Cells Market Size Market Share by Type (2017-2028)
Figure 24. Europe Engineered T Cells Market Size Market Share by Application (2017-2028)
Figure 25. Europe Engineered T Cells Market Size Share by Country (2017-2028)
Figure 26. Germany Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Engineered T Cells Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Engineered T Cells Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Engineered T Cells Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Engineered T Cells Market Size Share by Region (2017-2028)
Figure 36. China Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Engineered T Cells Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Engineered T Cells Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Engineered T Cells Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Engineered T Cells Market Size Share by Country (2017-2028)
Figure 46. Mexico Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Engineered T Cells Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Engineered T Cells Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Engineered T Cells Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Engineered T Cells Market Size Share by Country (2017-2028)
Figure 52. Turkey Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Engineered T Cells Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Autolus Limited Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 56. Bellicum Pharmaceuticals Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 57. Cells Medica Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 58. Elli Lilly and Company Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 59. Gilead Sciences Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 60. Juno Therapeutics Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 62. Oxford Biomedica Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 63. Pfizer Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 64. Precision Bioscience Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 65. Redmile Group Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 66. Seeking Alpha Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 67. Unum Therapeutics Revenue Growth Rate in Engineered T Cells Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Industry Market Size
